ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. (NDRA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · NDRA · as of Jun 30, 2023
Ownership Breakdown
1
Institutional Holders
$938
Total Inst. Value
▲ $320 vs Q1
752,631
Shares Outstanding
freeFloat 90.59%
670
13F Shares Held
▲ 400 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
NDRA largest shareholders · institutional ownership
Q2 2023 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
WORTH ASSET MANAGEMENT, LLC electromedical & electrotherapeutic apparatus | 670 | 1.12% | 1.12% | $938,000 | Jul 11, 2023 | ▲ 400 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2023 vs prior quarter
Q2 2023
1
Increased
+400 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+400
+400 / −0
Net new holders
+1
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
NDRA insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Tokman Alexander Y Chief Executive Officer | Mar 2, 2026 | Award | 26,921 | — | — | 101.9K | Form 4 ↗ |
Jacroux Richard Chief Financial Officer | Mar 2, 2026 | Award | 13,461 | — | — | 33.5K | Form 4 ↗ |
DIGIANDOMENICO ANTHONY director | Jan 21, 2026 | Award | 60,324 | — | — | 136.6K | Form 4 ↗ |
Harsh Michael director | Jan 21, 2026 | Award | 60,324 | — | — | 65.7K | Form 4 ↗ |
Jacroux Richard Chief Financial Officer | Jan 21, 2026 | Award | 20,000 | — | — | 20.0K | Form 4 ↗ |
Basenese Lou director | Jan 21, 2026 | Award | 60,324 | — | — | 65.7K | Form 4 ↗ |
Tokman Alexander Y Chief Executive Officer | Jan 21, 2026 | Award | 75,000 | — | — | 75.0K | Form 4 ↗ |
DIGIANDOMENICO ANTHONY director | Oct 10, 2025 | Award | 141,644 | $6.81 | $964.6K | 141.6K | Form 4 ↗ |
DIGIANDOMENICO ANTHONY director | Oct 10, 2025 | Award | 70,822 | $7.06 | $500.0K | 76.3K | Form 4 ↗ |
Basenese Lou director | Jun 11, 2025 | Award | 5,384 | — | — | 5.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ENDRA Life Sciences Inc. (NDRA) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 9.41%, while retail and public investors account for the remaining 90.51%.
The largest institutional shareholder of ENDRA Life Sciences Inc. is WORTH ASSET MANAGEMENT, LLC, holding approximately 670 shares — equal to 1.12% of outstanding shares — as of June 30, 2023.
A total of 1 institutional investors currently hold NDRA stock, with a combined institutional value of approximately $938 as of the most recent 13F filing period.
Frequently asked questions
NDRA ownershipENDRA Life Sciences Inc. (NDRA) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is WORTH ASSET MANAGEMENT, LLC with a 1.12% stake. Company insiders hold 9.41%. Data sourced from SEC Form 13F as of June 30, 2023.